On April 26, Ruifen Bio (839727) recently released the 2016 annual report showing that the operating income in 2016 was 26.5904 million yuan, an increase of 16.78% over the same period of the previous year; the net profit attributable to the shareholders of the listed company was 1.4813 million yuan, an increase of 17.54% over the same period of the previous year; the basic earnings per share was 0.26 yuan, compared with 0.68 yuan in the same period of the previous year.
As of 2016, the total assets of Ruifen Bio were 19.8993 million yuan, an increase of 9.49% over the end of the previous year. The asset-liability ratio was 38.25%, down 12.63 percentage points from 50.88% at the end of the previous year. Net cash flow from operating activities was -506,200 yuan for the current period, compared with 477,300 yuan in the same period last year.
During the reporting period, The operating income of Ruifen Bio increased by 16.78% over the same period of the previous year, mainly because Ruifen Bio opened up the domestic market under the premise of maintaining the stability of the original overseas sales market share, and the domestic sales revenue of Ruifen Bio in the current period was 6.3094 million yuan, an increase of 5.162 million yuan over the same period of the previous year of 1.1474 million yuan.
During the reporting period, the operating cost of Ruifen Bio increased by 22.36% over the same period of the previous year, mainly due to the corresponding increase in operating costs due to the increase in sales revenue on the one hand, and the increase in the cost of Ruifen Bio's main products on the other hand, due to the increase in raw material prices and labor costs.
According to the data of the New Third Board Research Institute, Ruifen Bio is located in the natural plant extract industry under the "C27 pharmaceutical manufacturing industry", and its main business is the research and development, production, sales and sales of related products such as pharmaceutical intermediates.
Some important matters during the reporting period:
Source Links:
http://www.neeq.com.cn/disclosure/2017/2017-04-24/1493033445_972127.pdf
Dig the shell net
For more exciting information, please visit the website of the financial community (www.jrj.com.cn)